Overview of Chronic Obstructive Pulmonary Disease Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.
The global Chronic Obstructive Pulmonary disease market will exhibit significant growth over the forecast period. The market is estimated to register a CAGR of 4.2% CAGR over the forecast period, which is higher compared to previous forecast period. Chronic obstructive pulmonary disease (COPD) drugs are used to treat is a chronic inflammatory lung disease, leads to obstructed airflow from the lungs. Some of the common systems associated with the disease include heavy breathing, coughing, and excessive mucus forming in the lungs, and wheezing. Complications associated with the COP disease include higher risk of developing heart disease, cancerous growth in lungs, and several other health conditions. There is rise in the patent expirations in the recent, which has been alarming fact for medical professionals, thereby aggravating need for advanced solution for the treatment of the disease.
Gets Sample of Global Chronic Obstructive Pulmonary Disease Market Report @ https://www.arcognizance.com/enquiry-sample/1220696
Other driver for the market such as the prevalence of chronic respiratory diseases, ne drug development and increasing focus towards R&D, and advanced homecare therapeutic devices will boost market over the forecast period. According to a report published by the World Health Organization in 2017, approximately 65 million people suffered from COPD globally. Yet, the government’s norms and regulation and approval of these drugs are predicted to hamper the market growth.
The global Chronic Obstructive Pulmonary Disease market is bifurcated on the basis of product, application, and geography. The product segment is further segmented into Emphysema, and Chronic Bronchitis. Based on Treatment, the market is segmented into Drugs, Surgery, and Oxygen Therapy. Geographically, the market is divided into North America, Europe, Asia-Pacific (APAC), Latin America, and Middle East & Africa (MEA). Based on application, market is segmented as Hospitals & Clinics, Home Care Settings, and Others.
Since the CoVID-19 outbreak in December 2019, the virus has spread worldwide. CoVID-19 is impacting business globally and is further expected to influence this market as well. CoVID-19 has been affecting global supply chains and thereby throwing the demand and supply gap haywire, leaving significant financial impact. This report analyzes the impact of CoVID-19 on this industry and provides apt conclusions for key business stakeholders. The Chronic Obstructive Pulmonary Disease market has been further divided into key countries. Some of the key players operating in the market include Abbott Laboratories (US), Circassia Pharmaceuticals (UK), Astellas Pharma, Boehringer Ingelheim, Novartis AG, Teva Pharmaceutical Industries Ltd (Israel), and GlaxoSmithKline.
Browse Global Chronic Obstructive Pulmonary Disease Industry Report @ https://www.arcognizance.com/report/chronic-obstructive-pulmonary-disease-market-global-industry-analysis-size-share-trends-and-forecast-2015-2025
Table of Content:
Chapter One: Market Introduction
Chapter Two: Executive Summary
Chapter Three: Global Chronic Obstructive Pulmonary Disease Market – Key Industry Dynamics
Chapter Four: Global Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025 – Product
- 1. Emphysema
- 2. Chronic Bronchitis
Chapter Five: Global Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025 – Treatment
- 1. Drugs
- 2. Surgery
- 3. Oxygen Therapy
Chapter Six: Global Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025 – Application
- 1. Hospitals & Clinics,
- 2. Home Care Settings
- 3. Others
Chapter Seven: Global Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025 – By Region
- 1. North America
- 2. Europe
- 3. Asia-Pacific
- 4. Latin America
- 5. Middle East & Africa
Chapter Eight: North America Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025
Chapter Nine: Europe Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025
Chapter Ten: Asia-Pacific Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eleven: Latin America Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025
Chapter Twelve: Middle East & Africa Chronic Obstructive Pulmonary Disease Market – Analysis and Revenue Forecast, 2015-2025
Chapter Thirteen: Competitive Analysis
- 1.1. Competition Dashboard
- 1.2. Company Profiles
- 1.2.1. GlaxoSmithKline
- 1.2.1.1. Company Details
- 1.2.1.2. Product Portfolio
- 1.2.1.3. Financial Overview
- 1.2.1.4. Main Business Overview
- 1.2.1.5. News
- 1.2.2. Abbott Laboratories (US)
- 1.2.3. Circassia Pharmaceuticals (UK).
- 1.2.4. Astellas Pharma
- 1.2.5. Boehringer Ingelheim.
- 1.2.6. Novartis AG
- 1.2.7. Teva Pharmaceutical Industries Ltd (Israel) co. ltd
Chapter Fourteen: Appendix
Chapter Fifteen: Research Conclusions
Make Enquiry of Chronic Obstructive Pulmonary Disease Market Report @ https://www.arcognizance.com/enquiry-before-buying/1220696
Buy Chronic Obstructive Pulmonary Disease Market Report @ https://www.arcognizance.com/purchase/1220696?license=single
About us: Analytical Research Cognizance (ARC) is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARC’s potential. ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.
Contact Us:
Ranjeet Dengale
Director Sales
Analytical Research Cognizance
+1 (646) 403-4695, +91 90967 44448
sales@arcognizance.com
